Lymphatic filariasis: possible pathophysiological nexus with oxidative stress

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 100, Issue 7, 2006, Pages 650-655

  Pal, B K ^a   Kulkarni, S ^a   Bhandari, Y ^a   Ganesh, Balaji B ^a   Goswami, K ^a   Reddy, M V R ^a  

^a MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Inflammation; Lymphatic filariasis; Oxidative stress; Wuchereria bancrofti

Indexed keywords

ANTIOXIDANT; DIETHYLCARBAMAZINE; MALONALDEHYDE; PARASITE ANTIGEN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FILARIASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIPID PEROXIDATION; LYMPHATIC SYSTEM INFECTION; MAJOR CLINICAL STUDY; MALE; MICROFILARIA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREVALENCE; SPECTROPHOTOMETRY; SYMPTOMATOLOGY; WUCHERERIA BANCROFTI;

ADULT; ANTIGENS, HELMINTH; CHRONIC DISEASE; DIETHYLCARBAMAZINE; ELEPHANTIASIS, FILARIAL; FEMALE; FILARICIDES; HUMANS; INDIA; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RURAL HEALTH; SUPEROXIDE DISMUTASE;

WUCHERERIA BANCROFTI;

EID: 33747877011     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2005.10.017     Document Type: Article

References (30)

1. Alikhan A., Padigel U.M., Ramarao P.V., Adwani P., Reddy M.V.R., Chaturvedi P., and Harinath B.C. Filarial antibody and antigen detection in different clinical conditions in an endemic area. Indian J. Clin. Biochem. 9 (1994) 31-34
2. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12 (1994) 141-179
3. Biswas T., Ghosh D.K., Mukherjee N., and Ghosal J. Lipid peroxidation of erythrocytes in visceral Leishmaniasis. J. Parasitol. 83 (1997) 151-152
4. Catty D., and Raykundalia C. Production and quality control of polyclonal antibodies. In: Catty D. (Ed). Antibodies (1988), IRL Press, Oxford, Washington 19-79
5. Erel O., Kocyigit A., Avci S., Aktepe N., and Bulut V. Oxidative stress and antioxidative status of plasma and erythrocytes in patients with vivax malaria. Clin. Biochem. 30 (1997) 631-639
6. Fidelus R.K., and Tsan M.F. Enhancement of intracellular glutathione promotes lymphocyte activation by mitogen. Cell. Immunol. 97 (1986) 155-163
7. Freedman D.O., De Almedio Filho P.J., Besh S., Canmelita M., Silva M., Cynthia B., and Maciel A. Lymphoscintigraphic analysis of lymphatic abnormalities in asymptomatic bancroftian filariasis. J. Infect. Dis. 170 (1994) 927-933
8. Friis H., Kaestel P., Nielsen N., and Simonsen P.E. Serum ferritin, alpha-tocopherol, beta-carotene and retinol levels in lymphatic filariasis. Trans. R. Soc. Trop. Med. Hyg. 96 (2002) 151-156
9. Gharib B., Abdallahi O.M., Dessein H., and De Reggi M. Development of eosinophil peroxidase activity and concomitant alteration of the antioxidant defences in the liver of mice infected with Schistosoma mansoni. J. Hepatol. 30 (1999) 594-602
10. Harinath B.C., Padigel U.M., Devi K.K., and Reddy M.V.R. Diagnosis and immunomonitoring in management of lymphatic filariasis in an endemic area. J. Parasitic Dis. 20 (1996) 35-40
11. Harinath B.C., Reddy M.V.R., Bhunia B., Bhandari Y.P., Mehta V.K., Chaturvedi P., Prajapati N.C., and Gupta R.K.C. Filaria associated clinical manifestations in children in an endemic area and morbidity control by immunomonitoring and optimal DEC therapy: Sevagram experience. Indian J. Clin. Biochem. 15 (2000) 118-126
12. Joharaprkar A.A., Zambad S.P., Wanjari M.M., and Umathe S.N. In vivo evaluation of antioxidant activity of alcoholic extract of Rubia Cordifolia linn. and its influence on ethanol-induced immunosuppression. Indian J. Pharmacol. 35 (2003) 232-236
13. Kaliraj P., Harinath B.C., and Ghirnikar S.N. Fractionation and evaluation of Wuchereria bancrofti microfilarial antigens in immunodiagnosis of bancroftian filariasis. Indian J. Exp. Biol. 20 (1982) 440-444
14. Kanesa-thasan N., Douglas J.G., and Kazura J.W. Diethylcarbamazine inhibits endothelial and microfilarial prostanoid metabolism in vitro. Mol. Biochem. Parasitol. 49 (1991) 11-19
15. Kazura J.W. Filariasis. In: Guerrant R.L., Walker D.H., and Weller P.F. (Eds). Tropical Infectious Diseases: Principles, Pathogens and Practice. first ed. (1999), Churchill Livingstone, Philadelphia, PA 852-860
16. Koedel U., and Pfister H.W. Oxidative stress in bacterial meningitis. Brain Pathol. 9 (1999) 57-67
17. Kumar V., Abbas A.K., and Fausto N. Pathologic Basis of Disease. seventh ed. (2004), Saunders, Philadelphia, PA
18. Kwiatkowska S., Piasecka G., Zieba M., Piotrowski W., and Nowak D. Increased serum concentrations of conjugated dienes and malondialdehyde in patients with pulmonary tuberculosis. Resp. Med. 93 (1999) 272-276
19. Maizels R.M., Bundy D.A., Selkirk M.E., Smith D.F., and Anderson R.M. Immunological modulation and evasion by helminth parasites in human populations. Nature 365 (1993) 797-805
20. Marie L.F., and Ramwell P.W. The eicosanoids: prostaglandins, thromboxanes, leukotrienes and related compounds. In: Katzung B.G. (Ed). Basic and Clinical Pharmacology. ninth ed. (2004), McGraw-Hill (International Edition), Boston 298-312
21. Marklund S. Extra cellular superoxide dismutase in human tissues and human cell lines. J. Clin. Invest. 74 (1984) 1398-1403
22. Mayes P.A., and Botham K.M. Metabolism of unsaturated fatty acids and eicosanoids. In: Murray R.K., Granner D.K., Mayes P.A., and Rodwell V.W. (Eds). Harper's Illustrated Biochemistry. twenty-sixth ed. (2003), McGraw-Hill (International Edition), Boston 190-196
23. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K., and Roberts L.J. A series of prostaglandin F2 like compounds are produced in vivo in humans by a noncyclooxygenase, free radical catalyzed mechanism. Proc. Natl. Acad. Sci. USA 87 (1990) 9383-9387
24. Nutman T.B., and Weller P.F. Filariasis and related infections. In: Kasper D.L., Fauci A.S., Longo D.L., Braunwald E., Hauser S.L., and Jameson J.L. (Eds). Harrison's Principle of Internal Medicine. sixteenth ed. (2005), McGraw-Hill, New York 1260-1266
25. Ottesen E.A. Immunopathology of lymphatic filariasis in man. Springer Semin. Immunopathol. 2 (1980) 373-385
26. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin. Chim. Acta 90 (1978) 37-43
27. Segal, A.W., Allison, A.C., 1978. Oxygen consumption by stimulated human neutrophils, in: Ciba Foundation Symposium 65 (New series), Oxygen Free Radicals and Tissue Damage. Excerpta Medica, Amsterdam, pp. 205-223.
28. Tracy J.W., and Webster Jr. L.T. Drugs used in the chemotherapy of helminthiasis. In: Hardman J.G., and Limbird L.E. (Eds). Goodman and Gilman's The Pharmacologic Basis of Therapeutics. tenth ed. (2001), McGraw-Hill, New York 1121-1140
29. WHO, 1987. Control of lymphatic filariasis: a manual for health personnel. World Health Organization, Geneva.
30. Zuo L., Christofi F.L., Wright V.P., Bao S., and Clanton T.L. Lipoxygenase-dependent superoxide release in skeletal muscle. J. Appl. Physiol. 97 (2004) 661-668